Condition
No Pill
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Early P 1 (1)
P 1 (1)
P 4 (1)
Trial Status
Completed1
Enrolling By Invitation1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07466628Phase 4Completed
Effects of Caffeine Ingestion on Morning Cognitive and Muscle Strength Measures in Males
NCT07466732Early Phase 1Enrolling By Invitation
Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males
NCT07469852Phase 1Active Not Recruiting
Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males
Showing all 3 trials